IDEAYA Biosciences Files 2024 10-K
Ticker: IDYA · Form: 10-K · Filed: Feb 18, 2025 · CIK: 1676725
| Field | Detail |
|---|---|
| Company | Ideaya Biosciences, Inc. (IDYA) |
| Form Type | 10-K |
| Filed Date | Feb 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
IDEAYA Bio filed its 2024 10-K. All systems go for drug dev.
AI Summary
IDEAYA Biosciences, Inc. filed its 2024 10-K report on February 18, 2025, detailing its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is headquartered in South San Francisco, California. The filing covers various aspects of its business, including financial performance, operations, and risk factors, as it continues its work in drug development.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of IDEAYA Biosciences' financial health and strategic direction for the fiscal year 2024, crucial for understanding its ongoing drug development progress.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, IDEAYA Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the financial statements in the 10-K.)
- 2025-02-18 — Filing Date (The date the 10-K was officially submitted to the SEC.)
- 001-38915 — SEC File Number (The company's assigned SEC file number.)
- 0000950170-25-022183 — Accession Number (Unique identifier for this specific SEC filing.)
Key Players & Entities
- IDEAYA Biosciences, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-18 (date) — Filing date
- South San Francisco, California (location) — Company headquarters and business address
- 5000 Shoreline Ct, Suite 300 (address) — Company business and mailing address
FAQ
What is the primary business of IDEAYA Biosciences, Inc.?
IDEAYA Biosciences, Inc. is primarily involved in pharmaceutical preparations, as indicated by its Standard Industrial Classification code [2834].
Where is IDEAYA Biosciences, Inc. headquartered?
The company's business and mailing address is located at 5000 Shoreline Ct, Suite 300, South San Francisco, California, 94080.
When did IDEAYA Biosciences, Inc. file its 10-K report for the fiscal year ending December 31, 2024?
The 10-K report was filed on February 18, 2025.
What is the SEC file number for IDEAYA Biosciences, Inc.?
The SEC file number for IDEAYA Biosciences, Inc. is 001-38915.
What is the fiscal year end for IDEAYA Biosciences, Inc.?
The fiscal year end for IDEAYA Biosciences, Inc. is December 31.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 18, 2025 regarding IDEAYA Biosciences, Inc. (IDYA).